Verrica Pharmaceuticals Inc (VRCA) — Financial Flexibility Index
Verrica Pharmaceuticals Inc (VRCA) has a Financial Flexibility Index of -0.40x as of March 2026. Free cash flow of $-9.16 Million (operating CF $-9.16 Million minus capex $0.00) represents 0% of total liabilities ($22.73 Million). Check Verrica Pharmaceuticals Inc (VRCA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verrica Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Verrica Pharmaceuticals Inc across 10 annual periods. See VRCA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Verrica Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Verrica Pharmaceuticals Inc. For the full company profile including market capitalisation, see Verrica Pharmaceuticals Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.79x | $-17.63 Million | $-17.63 Million | $22.39 Million | ▲ +17.3% |
| 2024 | -0.95x | $-60.90 Million | $-60.93 Million | $63.99 Million | ▼ -54.0% |
| 2023 | -0.62x | $-38.22 Million | $-38.58 Million | $61.83 Million | ▲ +84.2% |
| 2022 | -3.91x | $-18.35 Million | $-18.65 Million | $4.69 Million | ▼ -596.6% |
| 2021 | -0.56x | $-26.70 Million | $-27.58 Million | $47.52 Million | ▲ +19.5% |
| 2020 | -0.70x | $-28.74 Million | $-30.21 Million | $41.17 Million | ▲ +91.1% |
| 2019 | -7.84x | $-26.73 Million | $-27.41 Million | $3.41 Million | ▼ -13.6% |
| 2018 | -6.90x | $-17.10 Million | $-17.87 Million | $2.48 Million | ▼ -2822.3% |
| 2017 | -0.24x | $-3.81 Million | $-4.58 Million | $16.12 Million | ▲ +9.5% |
| 2016 | -0.26x | $-837.00K | $-1.61 Million | $3.21 Million | — |